Functional interactions of IL2 and TNF in the differentiation of LGL into lak effectors
- 15 October 1989
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 44 (4), 598-604
- https://doi.org/10.1002/ijc.2910440407
Abstract
We have previously reported on the synergistic effect of IL2 and TNF on the differentiation of LGL into LAK effectors. In the present study, we have further investigated the molecular basis of this synergistic mechanism and examined the role of TNF in the induction of LAK activity. We show that the generation of optimal LAK activity by low doses of IL‐2 in the presence of TNF involves the induction of high‐affinity IL2 receptors on LGL and occurs without promoting significant proliferation, suggesting a functional activation rather than a proliferative expansion of LAK precursors. Using blocking studies with anti‐Tac and with an anti‐IL2 (IHII), which specifically inhibits the binding of IL2 to the p75 IL2 receptor component, we also show that both the p55 and the p75 are involved in the increase in TNF binding sites on LGL and the subsequent acquisition of LAK activity. We also demonstrate that the failure of low doses of IL2 to induce LAK activity is related to their incapacity to induce TNF production. Moreover, when specific antibodies against TNF were added to the culture, the differentiation of LGL into LAK effectors by optimal concentrations of IL2 in our system (2.5–5.0 ng/ml) was partially inhibited. This suggests that TNF may be a physiologic mediator in the sequential activation stages of LGL into LAK effectors.This publication has 46 references indexed in Scilit:
- Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2.Proceedings of the National Academy of Sciences, 1988
- Noncytocidal Mechanisms of Action of Tumor Necrosis Factor-α on Human Tumor Cells: Enhancement of HLA Gene Expression Synergistic with Interferon-γImmunobiology, 1986
- Natural killer susceptibility of human cells may be regulated by genes in the HLA region on chromosome 6.Proceedings of the National Academy of Sciences, 1986
- Cachectin and tumour necrosis factor as two sides of the same biological coinNature, 1986
- Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.The Journal of Experimental Medicine, 1985
- "Anomalous" THY-1(+) killer cells in allogeneic and F1-anti-parental mixed leukocyte culture. Relation to natural killer cells and allospecific cytotoxic T lymphocytesThe Journal of Experimental Medicine, 1982
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Natural Killer Cells: Their Roles in Defenses Against DiseaseScience, 1981
- An endotoxin-induced serum factor that causes necrosis of tumors.Proceedings of the National Academy of Sciences, 1975
- The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Application to the radioimmunoassayBiochemical Journal, 1973